PARALLEL SESSION 3B: Neurogenetics II
Tracks
SKALKOTAS HALL
| Thursday, September 19, 2019 |
| 10:30 AM - 12:15 PM |
| SKALKOTAS HALL |
Speaker
Prof. Robert Steinfeld
Pediatric Neurology Department, University Children’s Hospital Zurich - Eleonore Foundation
New therapies
10:30 AM - 10:55 AM
Dr. Apostolos Papandreou
University College London, MRC Laboratory For Molecular Cell Biology
OC046 | The use of a patient-centric neuronal cell model of Beta-Propeller Protein-Associated Neurodegeneration (BPAN) as a drug screening platform to develop novel therapies
Dr. Alfonso Oyarzabal
Fundació Sant Joan De Deu
OC047 | Comprehensive analysis of GABA(A1R) developmental alterations in Rett Syndrome, a novel therapeutic target
Dr. Francesca Fumagalli
San Raffaele Scientific Institute
OC048 | Hematopoietic Stem Cell Gene Therapy for Mucopolysaccharidosis Type I, Hurler Variant (MPS-IH)
Prof. Kürşad Aydin
Medipol University Bagcilar
OC049 | The MRI patterns may be an important clue in the early diagnosis of CLN2
Dr. Ayelet Zerem
Pediatric Neurology Unit, E. Wolfson Medical Center
OC050 | Brain white matter abnormalities associated with copy number variants
.
Discussion
12:10 PM - 12:15 PMChair
Styliani Fidani
19/9
Department of Medical Biology-Genetics, Faculty of Medicine, Aristotle University of Thessaloniki
Maria Kinali
Imperial College London And Hca Healthcare Uk
